Literature DB >> 1814333

Risk factors and HIV seropositivity among injecting drug users in Bangkok.

K Choopanya1, S Vanichseni, D C Des Jarlais, K Plangsringarm, W Sonchai, M Carballo, P Friedmann, S R Friedman.   

Abstract

Bangkok experienced an extremely rapid spread of HIV infection among drug injectors in 1987 and 1988. This study examines risk factors for HIV infection and deliberate risk-reduction efforts by drug injectors. Two subsamples of injecting drug users were recruited in November 1989, a group in drug-use treatment (n = 342) and a group new to the treatment system (n = 259). Subjects were interviewed about AIDS risk behavior, and a blood sample was collected for HIV testing. Seroprevalence was 39 and 27% in the in-treatment sample and the new-to-treatment sample, respectively. The in-treatment sample seroprevalence rate is similar to rates observed 6 and 12 months earlier. Three factors were independently associated with HIV infection: subsample, having been in prison, and sharing injection equipment with two or more individuals in the previous 6 months. Deliberate risk reduction was reported by 92% of individuals, with 59% reporting that they had stopped sharing injection equipment. It appears that large-scale risk reduction has greatly slowed HIV transmission among drug injectors in Bangkok.

Entities:  

Keywords:  Asia; Behavior--changes; Biology; Cross Sectional Analysis; Data Collection; Demographic Factors; Developing Countries; Diseases; Drug Usage; Hiv Infections--transmission; Incidence; Interviews; Iv Drug Users; Measurement; Population; Population Characteristics; Research Methodology; Risk Factors; Risk Reduction Behavior; Southeastern Asia; Thailand; Urban Population; Viral Diseases

Mesh:

Year:  1991        PMID: 1814333     DOI: 10.1097/00002030-199112000-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  18 in total

1.  Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study.

Authors:  Aumphornpun Buavirat; Kimberly Page-Shafer; G J P van Griensven; J S Mandel; J Evans; J Chuaratanaphong; S Chiamwongpat; R Sacks; A Moss
Journal:  BMJ       Date:  2003-02-08

2.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities.

Authors:  A H Kral; R N Bluthenthal; R E Booth; J K Watters
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

Review 3.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

4.  Outbreak of HIV infection in a Scottish prison.

Authors:  A Taylor; D Goldberg; J Emslie; J Wrench; L Gruer; S Cameron; J Black; B Davis; J McGregor; E Follett
Journal:  BMJ       Date:  1995-02-04

Review 5.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

Review 6.  HIV infection and surgeons.

Authors:  E Y Lin; F C Brunicardi
Journal:  World J Surg       Date:  1994 Sep-Oct       Impact factor: 3.352

7.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

8.  AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.

Authors:  D C Des Jarlais; K Choopanya; S Vanichseni; K Plangsringarm; W Sonchai; M Carballo; P Friedmann; S R Friedman
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

9.  AIDS in Thailand: a medical student's perspective.

Authors:  D C Chow
Journal:  J Community Health       Date:  1994-12

10.  Reports of evidence planting by police among a community-based sample of injection drug users in Bangkok, Thailand.

Authors:  Nadia Fairbairn; Karyn Kaplan; Kanna Hayashi; Paisan Suwannawong; Calvin Lai; Evan Wood; Thomas Kerr
Journal:  BMC Int Health Hum Rights       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.